Seek Returns

ELAN vs. WST: Elanco Animal Health vs. West Pharmaceutical Services Stock Comparison

How do Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but ELAN is classified in Pharmaceuticals while WST is classified in Life Sciences Tools & Services.

Company profile comparison for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST)
Profile ItemELANWST
NameElanco Animal Health IncorporatedWest Pharmaceutical Services Inc.
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticalsLife Sciences Tools & Services
GICS Sub-IndustryPharmaceuticalsLife Sciences Tools & Services
Market Capitalization12.86 billion USD27.85 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateSeptember 20, 2018March 17, 1980
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

ELAN
WST
GSPC
Loading price history…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST)
MetricELANWST
Total Return (1Y)24.03%51.68%
Total Return (3Y, Annualized)37.47%7.13%
Total Return (5Y, Annualized)-4.24%0.05%

Risk Profile

Drawdown History

ELAN
WST
GSPC
Loading price history…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST)
MetricELANWST
Volatility (1Y, Annualized)43.57%31.45%
Beta (5Y)1.651.13
Max Drawdown (5Y)-75.59%-59.29%
Avg. Volume (3M)5.65M603.86K

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ELAN and WST are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST)
MetricELANWST
Sharpe Ratio (1Y)0.451.51
Sortino Ratio (1Y)0.662.35

Profitability

ROE (TTM)

Capital efficiency shows on one side only: West Pharmaceutical Services (WST) earns 21.23% on shareholders’ equity, ranked against its industry; Elanco Animal Health (ELAN) has no ROE this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ELAN
--

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

21.23%

Max
109.18%
WST
21.23%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): ELAN does not report ROE, so it has no value marker; WST is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

Elanco Animal Health (ELAN) reports a negative net margin of -2.86%, usually indicating a net loss over the period. Meanwhile West Pharmaceutical Services (WST) reports 18.81%, ranking against industry peers normally.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-2.86%

Max
18.05%
Q3
4.78%
Median
0.00%
ELAN
-2.86%
Q1
-4.14%
Min
-17.05%

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.81%

WST
18.81%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

West Pharmaceutical Services (WST) at 25.37% operates in the top operating margin quartile, ahead of Elanco Animal Health (ELAN) at 6.64%, which runs around its industry’s norm.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.64%

Max
83.12%
Q3
14.77%
ELAN
6.64%
Median
0.00%
Q1
-78.82%
Min
-207.40%

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

25.37%

Max
83.12%
WST
25.37%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST)
MetricELANWST
ROE (TTM)--21.23%
ROA (TTM)--11.89%
Net Margin (TTM)-2.86%18.81%
Operating Margin (TTM)6.64%25.37%
Gross Margin (TTM)56.18%37.59%

Growth

Revenue Growth

Both Elanco Animal Health (ELAN) at 6.22% and West Pharmaceutical Services (WST) at 6.25% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): A comparison of their Revenue Growth across different time periods.

EPS Growth

West Pharmaceutical Services (WST) at 1.49% is around its peer norm for EPS growth, while Elanco Animal Health (ELAN) at -169.12% drops into the bottom quartile, signaling weaker earnings momentum.

Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST)
MetricELANWST
Revenue Growth (YoY)6.22%6.25%
Revenue Growth (3Y CAGR)2.25%2.12%
EPS Growth (YoY)-169.12%1.49%
EPS Growth (3Y CAGR)---4.23%

Financial Strength

Current Ratio (MRQ)

Short-term liquidity can only be read on one side of this pairing: West Pharmaceutical Services (WST) shows current ratio of 2.82 against its industry benchmark, while Elanco Animal Health (ELAN) has no reading this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
Min
0.10
ELAN
--

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.82

Max
25.13
Q3
12.13
Median
5.52
WST
2.82
Q1
2.47
Min
0.10
Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): ELAN does not report current ratio, so it has no value marker; WST is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Debt / Equity (MRQ)

Both Elanco Animal Health (ELAN) at 0.64 and West Pharmaceutical Services (WST) at 0.11 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.64

Max
1.42
Q3
0.65
ELAN
0.64
Median
0.15
Q1
0.02
Min
0.00

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.11

Max
1.42
Q3
0.65
Median
0.15
WST
0.11
Q1
0.02
Min
0.00
Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST)
MetricELANWST
Current Ratio (MRQ)--2.82
Debt / Equity (MRQ)0.640.11
Net Debt / EBITDA3.49-0.16

Dividends

Dividend Yield (TTM)

Elanco Animal Health (ELAN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile West Pharmaceutical Services (WST) reports a yield of 0.22%, ranking against industry peers normally.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.22%

WST
0.22%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Elanco Animal Health (ELAN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile West Pharmaceutical Services (WST) reports a payout of 9.88%, ranking against industry peers normally.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.88%

WST
9.88%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST)
MetricELANWST
Dividend Yield (TTM)0.00%0.22%
Dividend Payout Ratio (TTM)0.00%9.88%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: West Pharmaceutical Services (WST) trades at 44.87 times trailing earnings, ranked against its peers, while Elanco Animal Health (ELAN) has no P/E ratio this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
ELAN
--

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

44.87

Max
85.34
WST
44.87
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): ELAN does not report P/E ratio, so it has no value marker; WST is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

Elanco Animal Health (ELAN) at 2.50 sits in the cheaper P/S ratio quartile while West Pharmaceutical Services (WST) at 8.20 prices around its industry’s middle — ELAN costs less per dollar of sales, though read it alongside growth and margins.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.50

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
ELAN
2.50
Min
0.01

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.20

Max
58.18
Q3
25.77
WST
8.20
Median
7.30
Q1
3.01
Min
0.01
Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Elanco Animal Health (ELAN) at 1.95 is valued about in line with its industry on P/B ratio, while West Pharmaceutical Services (WST) at 9.40 carries an above-peer premium to book — WST is pricier on assets.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.95

Max
13.53
Q3
6.54
Median
3.25
ELAN
1.95
Q1
1.69
Min
-5.59

WST

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.40

Max
13.53
WST
9.40
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
Elanco Animal Health (ELAN) vs. West Pharmaceutical Services (WST): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Elanco Animal Health (ELAN) and West Pharmaceutical Services (WST)
MetricELANWST
P/E Ratio (TTM)--44.87
P/S Ratio (TTM)2.508.20
P/B Ratio (MRQ)1.959.40
Free Cash Flow Yield (TTM)--1.24%